Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-12-010600
Filing Date
2012-01-12
Accepted
2012-01-12 16:13:26
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d278485ds3.htm S-3 166676
2 OPINION OF COOLEY LLP d278485dex51.htm EX-5.1 6539
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d278485dex231.htm EX-23.1 2567
4 GRAPHIC g278485newpicture.jpg GRAPHIC 3123
5 GRAPHIC g278485newpicture1.jpg GRAPHIC 2256
  Complete submission text file 0001193125-12-010600.txt   184671
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-178984 | Film No.: 12524401
SIC: 2835 In Vitro & In Vivo Diagnostic Substances